Provenance du réseau au premier degré de Benjamin Kim
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 21 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Benjamin Kim via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| BAXTER INTERNATIONAL INC. | Medical Specialties | Director of Finance/CFO | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Treasurer Director/Board Member | |
| THE GOLDMAN SACHS GROUP, INC. | Investment Banks/Brokers | Corporate Officer/Principal | |
| CARMAX, INC. | Specialty Stores | Director/Board Member | |
Biothera, Inc.
 Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Biothera, Inc. develops natural gluco polysaccharide that engages and directs natural innate immune systems. The company was founded by Daniel Conners in 1997 and is headquartered in Eagan, MN. | Miscellaneous Commercial Services | Director/Board Member | |
Naurex, Inc.
 Naurex, Inc. Pharmaceuticals: MajorHealth Technology Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL. | Pharmaceuticals: Major | Director/Board Member | |
| SEMLER SCIENTIFIC, INC. | Medical Specialties | Chief Executive Officer | |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| BAXALTA INC | Biotechnology | Director of Finance/CFO | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree | |
| University of Oxford | College/University | Corporate Officer/Principal | |
DuPont Merck Pharmaceutical Co.
 DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Part of Corteva, Inc., DuPont Merck Pharmaceutical Co. is a private company that makes pharmaceuticals and drugs. The company is based in Wilmington, DE. DuPont Merck Pharmaceutical was acquired by EIDP, Inc., a subsidiary of Corteva, Inc. from Merck & Co., Inc. on July 01, 1998 for $2,600 million. | Pharmaceuticals: Major | Sales & Marketing | |
| FIBROGEN, INC. | Pharmaceuticals: Major | Director/Board Member | |
| MIRATI THERAPEUTICS | Biotechnology | Director/Board Member | |
| The University of Colorado | College/University | Undergraduate Degree Doctorate Degree | |
| University of Puget Sound | College/University | Undergraduate Degree | |
Loyola University Health System
 Loyola University Health System Hospital/Nursing ManagementHealth Services Loyola University Health System engages in the provision of healthcare services. It offers primary care, surgical, digestive health programs, orthopedics, neurology and neurosurgery, transplant, and other medical services. The company is headquartered in Maywood, IL. | Hospital/Nursing Management | Director/Board Member | |
Fred Hutchinson Cancer Research Center
 Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Fred Hutchinson Cancer Research Center is a non-profit organization which provides research and testing services. The company was founded in 1965 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Qiming Venture Partners Ltd.
 Qiming Venture Partners Ltd. Investment ManagersFinance Qiming Venture Partners Ltd (Qiming Venture Partners) is a venture capital subsidiary of Qiming Caymen Ltd founded in 2006 by Gary Rieschel, Zi Ping Kuang and Ignition Partners LLC. The firm is headquartered in Shanghai, China. | Investment Managers | Private Equity Investor | |
| Glaxo, Inc. | Corporate Officer/Principal | ||
| AUSPEX PHARMACEUTICALS INC | Pharmaceuticals: Major | President | |
| Baxter International Foundation | President | ||
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
National Human Genome Research Institute
 National Human Genome Research Institute General GovernmentGovernment National Human Genome Research Institute engages in genetic and genomic research. It provides guidance to scientific programs and oversees the general operation. The company was founded in 1989 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal | |
Dupont De Nemours & Co., Inc.
 Dupont De Nemours & Co., Inc. Agricultural Commodities/MillingProcess Industries Part of Corteva, Inc., Dupont De Nemours & Co., Inc. is a private company that manufactures hybrid corn and soybean seeds. The company is based in Wilmington, DE. | Agricultural Commodities/Milling | Sales & Marketing | |
Ziarco Pharma Ltd.
 Ziarco Pharma Ltd. BiotechnologyHealth Technology Ziarco Pharma Ltd. provides therapeutics targeting inflammatory and allergic diseases. It focuses on chronic inflammatory skin diseases, atopic dermatitis, and Psoriasis. The company was founded by Michael Yeadon, Wai Leung Liu, Lynn Worth Purkins and Arif Kassam Shivji in 2012 and is headquartered in Sandwich, the United Kingdom. | Biotechnology | Chairman | |
| Kellogg School of Management | College/University | Masters Business Admin | |
Ziarco Group Ltd.
 Ziarco Group Ltd. Pharmaceuticals: MajorHealth Technology Ziarco Group Ltd. operates as a clinical-stage biotechnology company that develops therapeutics targeting inflammatory skin diseases. The firm engages in development of novel treatments in dermatology. The company was incorporated on March 10, 2014 and is headquartered in Canterbury, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
| RENEO PHARMACEUTICALS, INC. | Biotechnology | Founder Director/Board Member | |
Balance Therapeutics, Inc.
 Balance Therapeutics, Inc. BiotechnologyHealth Technology Balance Therapeutics, Inc. develops therapeutics to address conditions of intellectual disability. Its pharmacological approach, based on technology licensed from Stanford University, hypothesizes that restoring the proper balance between inhibition and excitation at the neuronal synapse by antagonizing excessive inhibitory circuits could result in the appropriate plasticity for memory and learning to occur in many conditions of intellectual disability. The company was founded by Lyndon Lien, Craig Garner and Daniel Wetmore in 2009 and is headquartered in San Bruno, CA. | Biotechnology | Director/Board Member | |
| APTINYX | Pharmaceuticals: Major | Director/Board Member | |
| Viridian Global Logistics, Inc. | Corporate Officer/Principal | ||
GRAIL LLC
 GRAIL LLC Electronic Equipment/InstrumentsElectronic Technology GRAIL LLC is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | Electronic Equipment/Instruments | Director/Board Member | |
EDGe Surgical, Inc.
 EDGe Surgical, Inc. Electronic Equipment/InstrumentsElectronic Technology EDGe Surgical, Inc. develops orthopedic and spine surgery instruments. The company was founded in 2015 and is headquartered in Chicago, IL. | Electronic Equipment/Instruments | Director/Board Member | |
Agent Capital LLC
 Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | Investment Managers | Consultant / Advisor | |
Samsara Biocapital LLC
 Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
| SPRUCE BIOSCIENCES, INC. | Biotechnology | Director/Board Member Chairman Director/Board Member Chief Executive Officer | |
Parexel International Corp. Ltd.
 Parexel International Corp. Ltd. Financial ConglomeratesFinance Parexel International Corp. Ltd. functions as an investment holding British company. The private company is based in Basingstoke, UK. | Financial Conglomerates | Director/Board Member | |
Institute For Protein Innovation, Inc.
 Institute For Protein Innovation, Inc. Miscellaneous Commercial ServicesCommercial Services Institute For Protein Innovation, Inc. is a non-profit company that focuses on enhancing the potential of recombinant antibodies. The company is based in Boston, MA. The company uses sophisticated yeast display technology to generate synthetic, recombinant antibodies. The company was founded by Andrew Kruse, Timothy A. Springer. Kenneth Fasman has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Director/Board Member | |
| MIRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
| Altius Institute For Biomedical Sciences | Founder | ||
| NEUMORA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| EMBECTA CORP. | Medical Specialties | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 42 |
| Royaume-Uni | 7 |
| Irlande | 2 |
| Chine | 2 |
| Canada | 2 |
Sectorielle
| Health Technology | 26 |
| Finance | 7 |
| Consumer Services | 6 |
| Commercial Services | 5 |
| Electronic Technology | 3 |
Opérationnelle
| Director/Board Member | 129 |
| Independent Dir/Board Member | 52 |
| Corporate Officer/Principal | 45 |
| President | 23 |
| Chief Executive Officer | 21 |
Relations les plus connectées
| Insiders | |
|---|---|
| Alan J. Lewis | 33 |
| Michael Grey | 32 |
| Kathryn Falberg | 30 |
| Elizabeth Anderson | 24 |
| Dan Spiegelman | 24 |
| Wayne T. Pan | 17 |
| May Kin Ho | 16 |
| Robert Hombach | 13 |
| Lon Cardon | 13 |
| Robert Baffi | 12 |
| Camilla Simpson | 12 |
| Barrie J. Carter | 9 |
| Richard J. Ranieri | 9 |
| Kevin Eggan | 8 |
| Edward Berg | 8 |
- Bourse
- Insiders
- Benjamin Kim
- Connexions Sociétés
